Literature DB >> 17723132

A genetic basis for the interrelation of coagulation factors.

C Y Vossen1, P W Callas, S J Hasstedt, G L Long, F R Rosendaal, E G Bovill.   

Abstract

BACKGROUND: Evidence found in the literature for a strong correlation between coagulation factors suggests that single genes might influence the plasma concentrations of multiple coagulation factors (i.e. pleiotropically acting genes).
OBJECTIVE: To determine whether there is a genetic basis for the correlation among coagulation factors by assessing the heritability of interrelated coagulation factors. PATIENTS/
METHODS: We performed principal components analysis, and subsequently variance components analysis, to estimate the heritability of principal components of coagulation factors in family members of a large French-Canadian kindred.
RESULTS: Four clusters were identified by principal components analysis in 200 family members who did not carry the protein C 3363C mutation. Cluster 1 consisted of prothrombin, factor VII (FVII), FIX, FX and protein S; cluster 2 consisted of FV, FIX, protein C and tissue factor pathway inhibitor; cluster 3 consisted of FVIII and von Willebrand factor; and cluster 4 consisted of antithrombin, protein C and FVII. The heritability of the principal components estimated by variance components analysis was, respectively, 37%, 100%, 37%, and 37%.
CONCLUSION: Our findings support the hypothesis that genes can influence plasma levels of interrelated coagulation factors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17723132     DOI: 10.1111/j.1538-7836.2007.02678.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  4 in total

1.  Genome scan of clot lysis time and its association with thrombosis in a protein C-deficient kindred.

Authors:  M E Meltzer; S J Hasstedt; C Y Vossen; P W Callas; Ph G DE Groot; F R Rosendaal; T Lisman; E G Bovill
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

2.  Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency.

Authors:  Connie Duckers; Paolo Simioni; Luca Spiezia; Claudia Radu; Sabrina Gavasso; Jan Rosing; Elisabetta Castoldi
Journal:  Blood       Date:  2008-08-11       Impact factor: 22.113

3.  Role of the PROS1 gene in thrombosis: lessons and controversies.

Authors:  Mary J Heeb
Journal:  Expert Rev Hematol       Date:  2008-10       Impact factor: 2.929

4.  Whole-Genome Approach Discovers Novel Genetic and Nongenetic Variance Components Modulated by Lifestyle for Cardiovascular Health.

Authors:  Xuan Zhou; Julius van der Werf; Kristin Carson-Chahhoud; Guiyan Ni; John McGrath; Elina Hyppönen; S Hong Lee
Journal:  J Am Heart Assoc       Date:  2020-04-20       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.